Spironolactone for children with NCOR gene changes and autism
Treatments studied
Part of Genetic & congenital, Mental health clinical trials.
This trial tests if spironolactone can help children with autism who have a certain genetic change (in the NCOR gene). The study will monitor improvement and safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be diagnosed with autism based on the ADOS-2 test.
- A genetic test (whole exome) must show a change in the NCOR gene.
- Your child must be between 3 and 10 years old.
- You and your child must agree to take part and allow data and blood/urine samples to be collected.
- Your child cannot have other more serious genetic changes, certain medical conditions, or have taken certain medications recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether omega-3 supplements can help children and teens with autism spectrum disorder (ASD). It aims to see if taking omega-3 improves core symptoms like social communication and behavior.
This trial tests whether spironolactone can help treat anemia in children aged 6-18 who are on hemodialysis. It may improve their response to current anemia treatments.
This trial tests whether spironolactone can reduce symptoms and inflammation in people with rheumatoid arthritis that is still active despite standard arthritis medicines. You may be able to join if your rheumatoid arthritis remains active and your current treatment plan has been stable for at least several months.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
Hear when a new ASD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.